A Phase 2, Multicenter, Single-arm Study of Zanubrutinib (BGB-3111) in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Intolerant of Prior Treatment with Ibrutinib (BGB-3111-215)

  • Details

ClinicalTrials.gov ID: NCT03206918
Diagnosis Type: NA
USOR Number: 18263

  • Address

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, CO 80228
P: (303) 430-2700

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.